← Eichor
Condition: Primary Secondary Prevention Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Secondary Prevention

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110
Colorectal Metastasis Prevention International Trial 2
Phase 2 · 6 location(s) · Assaf-Harofeh Medical Center · NCT03919461
A Hospital-Based Registry of Preventive Cardiology Clinics
Phase N/A · 1 location(s) · National Institute of Cardiovascular Diseases, Pakistan · NCT06503341
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031
Evaluation of a Personalised Digital Intervention (EviBody) for Healthy and Sustained Lifestyle Behaviors and Well-being
Phase N/A · 1 location(s) · Sophiahemmet University · NCT05973383
Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05504928
City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT07031089
Antibiotic Prophylaxis in Patients Undergoing GVO
Phase 4 · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT04140578
Prevention of Smoking Related Diseases
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06451029
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Phase N/A · 2 location(s) · University of Florence · NCT06409832
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's E
Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT06732388
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastati
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT03010150
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Phase 3 · 42 location(s) · Takeda · NCT06980480
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Phase N/A · 31 location(s) · University Hospital of Ferrara · NCT06324682
Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropen
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT07187908
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04982653
Community-Based Lifestyle Intervention for Diabetes Prevention in Arab Women
NA · 1 location(s) · Hadassah Medical Organization · NCT03358797
Emapalumab Prevention of CAR-T Cell Associated Toxicities
Phase 2 · 2 location(s) · Marcela V. Maus, M.D.,Ph.D. · NCT06550141
Etrasimod as Prevention of Pouchitis
Phase 2 · 1 location(s) · Maia Kayal · NCT07486921
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.